These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 26440757)
1. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells. Kesharwani P; Banerjee S; Padhye S; Sarkar FH; Iyer AK Biomacromolecules; 2015 Sep; 16(9):3042-53. PubMed ID: 26302089 [TBL] [Abstract][Full Text] [Related]
3. Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Kesharwani P; Banerjee S; Padhye S; Sarkar FH; Iyer AK Colloids Surf B Biointerfaces; 2015 Aug; 132():138-45. PubMed ID: 26037703 [TBL] [Abstract][Full Text] [Related]
4. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. Luong D; Kesharwani P; Killinger BA; Moszczynska A; Sarkar FH; Padhye S; Rishi AK; Iyer AK J Colloid Interface Sci; 2016 Dec; 484():33-43. PubMed ID: 27585998 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells. Li YF; Zhang HT; Xin L J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680 [TBL] [Abstract][Full Text] [Related]
6. Efficient targeted gene delivery by a novel PAMAM/DNA dendriplex coated with hyaluronic acid. Urbiola K; Sanmartín C; Blanco-Fernández L; Tros de Ilarduya C Nanomedicine (Lond); 2014 Dec; 9(18):2787-801. PubMed ID: 24959932 [TBL] [Abstract][Full Text] [Related]
7. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-grafted polyamidoamine dendrimers enable long circulation and active tumor targeting simultaneously. Qi X; Fan Y; He H; Wu Z Carbohydr Polym; 2015 Aug; 126():231-9. PubMed ID: 25933544 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells. Singh SP; Sharma M; Gupta PK Int J Biol Macromol; 2015 Mar; 74():162-70. PubMed ID: 25511568 [TBL] [Abstract][Full Text] [Related]
10. Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells. Jiang G; Li R; Tang J; Ma Y; Hou X; Yang C; Guo W; Xin Y; Liu Y Oncol Rep; 2017 Feb; 37(2):995-1001. PubMed ID: 28035395 [TBL] [Abstract][Full Text] [Related]
11. Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise Cancer Cell Targeting. Luong D; Sau S; Kesharwani P; Iyer AK Biomacromolecules; 2017 Apr; 18(4):1197-1209. PubMed ID: 28245646 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by HA for targeted gene delivery systems and evaluation Hu H; Wang H; Liang S; Li X; Wang D J Biomater Sci Polym Ed; 2021 Feb; 32(2):205-228. PubMed ID: 33035113 [TBL] [Abstract][Full Text] [Related]
14. Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery. Zhang X; Pan J; Yao M; Palmerston Mendes L; Sarisozen C; Mao S; Torchilin VP Eur J Pharm Biopharm; 2020 Sep; 154():43-49. PubMed ID: 32645383 [TBL] [Abstract][Full Text] [Related]
16. Chloroquine Assisted Delivery of microRNA Mimic Let-7b to NSCLC Cell Line by PAMAM (G5) - HA Nano-Carrier. Maghsoudnia N; Eftekhari RB; Sohi AN; Dorkoosh FA Curr Drug Deliv; 2021; 18(1):31-43. PubMed ID: 32753014 [TBL] [Abstract][Full Text] [Related]
17. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs. Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613 [TBL] [Abstract][Full Text] [Related]
18. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Hong S; Bielinska AU; Mecke A; Keszler B; Beals JL; Shi X; Balogh L; Orr BG; Baker JR; Banaszak Holl MM Bioconjug Chem; 2004; 15(4):774-82. PubMed ID: 15264864 [TBL] [Abstract][Full Text] [Related]
19. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide. Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212 [TBL] [Abstract][Full Text] [Related]
20. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]